Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer.

circulating tumor cells gene expression liquid biopsy qPCR tumor marker panel

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
16 Feb 2023
Historique:
received: 31 01 2023
revised: 13 02 2023
accepted: 13 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

Liquid biopsy is a promising tool for therapy monitoring of cancer patients, but a need for further research in this field exists in order to improve sensitivity, specificity, standardization and minimize costs. In our present study, we evaluated two panels of transcripts related with the presence of circulating tumor cells (CTCs) (Panel 1:

Identifiants

pubmed: 36831613
pii: cancers15041271
doi: 10.3390/cancers15041271
pmc: PMC9954525
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Oncol. 2006 Aug 10;24(23):3756-62
pubmed: 16769987
Breast Cancer Res. 2012 Aug 15;14(4):R118
pubmed: 22894854
J Natl Cancer Inst. 2018 Jun 1;110(6):560-567
pubmed: 29659933
Cancers (Basel). 2022 Oct 26;14(21):
pubmed: 36358657
Br J Cancer. 2009 Aug 18;101(4):589-97
pubmed: 19623181
Front Cell Dev Biol. 2022 Jun 28;10:929893
pubmed: 35837334
Cytometry A. 2018 Dec;93(12):1234-1239
pubmed: 30107082
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
Breast Cancer Res Treat. 2022 Nov;196(1):75-85
pubmed: 36074219
Gynecol Oncol. 2013 Jan;128(1):15-21
pubmed: 23017820
Clin Cancer Res. 2007 Feb 1;13(3):920-8
pubmed: 17289886
BMC Cancer. 2010 Dec 03;10:666
pubmed: 21129172
Int J Cancer. 2006 Oct 1;119(7):1654-9
pubmed: 16708381
Ann Oncol. 2010 Apr;21(4):729-733
pubmed: 19850639
Geburtshilfe Frauenheilkd. 2011 Dec;71(12):1067-1072
pubmed: 28435167
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Acta Oncol. 2011 Jun;50(5):700-10
pubmed: 21261508
J Clin Oncol. 2002 Aug 15;20(16):3404-12
pubmed: 12177100
JAMA Oncol. 2018 Dec 1;4(12):1700-1706
pubmed: 30054636
J Natl Cancer Inst. 2022 Mar 8;114(3):391-399
pubmed: 34747484
Br J Cancer. 2022 Jun;126(11):1563-1569
pubmed: 35145253
J Clin Oncol. 2016 Mar 20;34(9):927-35
pubmed: 26786933
Clin Cancer Res. 2016 May 15;22(10):2583-93
pubmed: 26733614
Biol Blood Marrow Transplant. 2004 Jun;10(6):415-25
pubmed: 15148495
J Natl Cancer Inst. 2014 May 15;106(5):
pubmed: 24832787
Clin Cancer Res. 2008 Nov 1;14(21):7004-10
pubmed: 18980996
Biomark Res. 2022 Aug 13;10(1):58
pubmed: 35962400
Br J Cancer. 2014 Jan 21;110(2):375-83
pubmed: 24366294

Auteurs

Eva Welsch (E)

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Eva Schuster (E)

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Michael Krainer (M)

Department of Medicine I, Clinical Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Maximilian Marhold (M)

Department of Medicine I, Clinical Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Rupert Bartsch (R)

Department of Medicine I, Clinical Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Michael B Fischer (MB)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Center for Biomedical Technology, Department for Biomedical Research, Danube University Krems, 3500 Krems, Austria.

Michael Hermann (M)

Brustgesundheitszentrum, Department of Surgery, Klinik Landstaße, Wiener Gesundheitsverbund, 1030 Vienna, Austria.

Gabriele Hastermann (G)

Brustgesundheitszentrum, Department of Surgery, Klinik Landstaße, Wiener Gesundheitsverbund, 1030 Vienna, Austria.

Heidemarie Uher (H)

Brustgesundheitszentrum, Department of Surgery, Klinik Landstaße, Wiener Gesundheitsverbund, 1030 Vienna, Austria.

Gerhard Sliutz (G)

Brustgesundheitszentrum, Department of Surgery, Klinik Landstaße, Wiener Gesundheitsverbund, 1030 Vienna, Austria.
Brustgesundheitszentrum, Department of Gynecology and Obstetrics, Klinik Landstaße, Wiener Gesundheitsverbund, 1030 Vienna, Austria.

Birgit Anker (B)

Brustgesundheitszentrum, Department of Gynecology and Obstetrics, Klinik Landstaße, Wiener Gesundheitsverbund, 1030 Vienna, Austria.

Robert Zeillinger (R)

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Eva Obermayr (E)

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.

Classifications MeSH